| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Loss before income taxes | -19,958 | -20,722 | -23,756 | 1,358 |
| Provision for (benefit from) income taxes | 906 | -825 | -619 | -238 |
| Loss before preferred dividends and accretion of series a preferred stock including excise tax | -20,864 | -19,897 | -23,137 | 1,596 |
| Dividends and accretion of series a preferred stock including excise tax | 6,066 | 31,193 | 8,094 | 7,979 |
| Net loss attributable to common shareholders of evolent health, inc. - diluted | -26,930 | -51,090 | -31,231 | -6,383 |
| Basic (in dollars per share) | -0.24 | -0.44 | -0.27 | -0.06 |
| Basic (in shares) | 114,066,000 | 115,882,000 | 114,862,000 | 114,688,000 |
| Diluted (in dollars per share) | -0.24 | -0.44 | -0.27 | -0.06 |
| Diluted (in shares) | 114,066,000 | 115,882,000 | 114,862,000 | 114,688,000 |
Evolent Health, Inc. (EVH)
Evolent Health, Inc. (EVH)